quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:09:08·122d
INSIDERFiling
CommScope Holding Company Inc. logo

SVP & President, CCS Ter Linde Koen covered exercise/tax liability with 171,977 shares, decreasing direct ownership by 24% to 531,541 units (SEC Form 4)

COMM· CommScope Holding Company Inc.
Technology
Original source

Companies

  • COMM
    CommScope Holding Company Inc.
    Technology

Recent analyst ratings

  • Aug 7UpdateBofA Securities$20.00
  • Aug 5UpdateRaymond James$19.00
  • Aug 5UpdateMorgan Stanley$17.00
  • Aug 4UpdateNorthland Capital$12.00
  • Jul 8UpdateWolfe Research-
  • Jan 14UpdateAnalyst$5.00

Related

  • SEC98d
    SEC Form 8-K filed by CommScope Holding Company Inc.
  • INSIDER101d
    SVP, GC & Chief Admin Officer Bowen Krista R. was granted 70,514 shares, increasing direct ownership by 25% to 357,797 units (SEC Form 4)
  • INSIDER101d
    SVP, Treasury, Tax & CAO Gilstrap Charles A was granted 51,915 shares, increasing direct ownership by 23% to 275,440 units (SEC Form 4)
  • INSIDER101d
    SVP & President, CCS Ter Linde Koen was granted 97,978 shares, increasing direct ownership by 18% to 629,519 units (SEC Form 4)
  • INSIDER101d
    SVP & President, ANS Sucharczuk Guy was granted 83,718 shares, increasing direct ownership by 14% to 691,579 units (SEC Form 4)
  • INSIDER101d
    SVP & President, NICS Giordano Bartolomeo was granted 83,718 shares, increasing direct ownership by 18% to 546,437 units (SEC Form 4)
  • INSIDER101d
    SVP and Chief HR Officer Mingle Robyn T was granted 76,757 shares, increasing direct ownership by 15% to 572,952 units (SEC Form 4)
  • INSIDER101d
    EVP & CFO Lorentzen Kyle David was granted 253,848 shares, increasing direct ownership by 14% to 2,050,126 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022